| Date | Form | Description | Docs | XBRL | Pages |
| 09/12/95 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 | |
| 09/06/95 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
15 | |
| 09/06/95 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 06/30/95 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
8 | |
| 06/27/95 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 06/14/95 | DEF 14A | Definitive proxy statements |
|
15 | |
| 06/09/95 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...